Related Experiment Video
Updated: Jun 1, 2026
07:39
Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model
Published on: August 4, 2023
The pediatric corneal infiltrate
1Department of Ophthalmology, New York Medical College, Westchester Medical Center, Valhalla, New York 10528, USA. pedkera@aol.com
Current Opinion in Ophthalmology
|May 21, 2011
Summary
Early diagnosis of pediatric corneal scarring and infiltrates is crucial. Key causes include keratoconus, phlyctenulosis, and herpes simplex keratitis, which can cause vision loss if untreated.
Area of Science:
- Ophthalmology
- Pediatric Eye Care
Background:
- Acquired corneal scarring and infiltrates in children can lead to irreversible vision loss.
- Prompt recognition and management are essential to prevent long-term visual impairment.
Purpose of the Study:
- To identify the primary causes of acquired corneal scarring and infiltrates in pediatric patients.
- To emphasize the importance of timely diagnosis and treatment for these conditions.
Main Methods:
- Review of recent ophthalmic literature.
- Synthesis of findings on common causes of pediatric corneal pathology.
Main Results:
- Limited recent literature exists on this topic.
- Consensus emphasizes the critical need for early diagnosis and intervention.
Conclusions:
- The most significant causes of corneal scarring or infiltrates in children are keratoconus, phlyctenulosis, and herpes simplex keratitis.
- These conditions require prompt identification and treatment to preserve vision.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...